Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The Eger Macular Stressometer: pilot study.

Nicholas J Schmitt1, Donald A Grover, Steven E Feldon

  • 1University of Rochester Department of Ophthalmology, Rochester, New York 14642, USA.

American Journal of Ophthalmology
|July 31, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Competency-Based Medical Education in Ophthalmology: Perspectives of Residency Program Directors.

Journal of surgical education·2026
Same author

Metformin inhibits PDGFβ signaling to suppress hyaluronan and cytokine production in thyroid eye disease.

Experimental eye research·2026
Same author

A Call to Action and Roadmap for Improving Emergency Treatment of Ophthalmic Trauma in the United States.

Ophthalmology·2025
Same author

Targeting the Aryl Hydrocarbon Receptor to Attenuate IGF1R Signaling in Thyroid Eye Disease.

Thyroid : official journal of the American Thyroid Association·2025
Same author

Tapinarof, an Aryl Hydrocarbon Receptor Ligand, Mitigates Fibroblast Activation in Thyroid Eye Disease: Implications for Novel Therapy.

Investigative ophthalmology & visual science·2024
Same author

Vision-related quality of life after unilateral occipital stroke.

Brain and behavior·2024
Same journal

Reply to Comment on Visual Field Progression in Glaucoma Patients with Delayed Follow-Up.

American journal of ophthalmology·2026
Same journal

Comment on: "Safety and efficiency reducing retinopathy of prematurity guideline sensitivity: an external validation using a large US-based dataset".

American journal of ophthalmology·2026
Same journal

Reply to Comment on "Clinicopathological and Imaging Distinction Between Ocular Adnexal MALT Lymphoma and IgG4-Related Ophthalmic Disease".

American journal of ophthalmology·2026
Same journal

Comment on: Visual Field Progression in Glaucoma Patients With Delayed Follow-Up.

American journal of ophthalmology·2026
Same journal

Corneal sensitivity changes and nerve plexus abnormalities in noninfectious anterior uveitis.

American journal of ophthalmology·2026
Same journal

Role of Menopausal Hormone Therapy on Strabismus, Strabismus Surgery, and Reoperation Rates.

American journal of ophthalmology·2026
See all related articles

The Eger Macular Stressometer (EMS) did not show different recovery times between age-related macular degeneration (AMD) and other eye conditions. Current EMS is not a sensitive tool for early AMD screening.

Area of Science:

  • Ophthalmology
  • Medical Devices
  • Diagnostic Tools

Background:

  • Age-related macular degeneration (AMD) is a leading cause of vision loss.
  • Early detection of AMD is crucial for timely intervention.
  • The Eger Macular Stressometer (EMS) is a device designed for macular function assessment.

Purpose of the Study:

  • To evaluate the sensitivity of the Eger Macular Stressometer (EMS) for early screening of age-related macular degeneration (AMD).
  • To test the hypothesis that eyes with AMD have different EMS recovery times compared to eyes with cataract, diabetic retinopathy, or glaucoma.

Main Methods:

  • A nonrandomized clinical trial involving 92 patients aged 50 and older with vision 20/80 or better.
  • Participants were categorized into four groups: AMD (30 eyes), normal/mild cataract (30 eyes), diabetic retinopathy (16 eyes), and glaucoma (16 eyes).

Related Experiment Videos

  • Recovery times (RTs) were measured using the EMS according to manufacturer's instructions.

    • Main Results:

    • Mean RTs were similar across all groups: AMD (11.8s), normal/cataract (10.0s), diabetic retinopathy (8.4s), and glaucoma (8.6s).
    • No significant differences in RTs were found between the groups (P =.58).
    • Recovery time was not related to age, visual acuity, or sex.

    Conclusions:

    • EMS recovery time distributions did not differ significantly between AMD, cataract, diabetic retinopathy, and glaucoma groups.
    • The EMS, in its current form, is not a sensitive screening tool for early detection of AMD.
    • Further research is recommended to assess EMS sensitivity for other macular diseases, including central serous choroidopathy and diabetic macular edema.